281 related articles for article (PubMed ID: 30256522)
1. Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway.
Sun S; Kee HJ; Jin L; Ryu Y; Choi SY; Kim GR; Jeong MH
J Cell Mol Med; 2018 Dec; 22(12):5964-5977. PubMed ID: 30256522
[TBL] [Abstract][Full Text] [Related]
2. Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure.
Sun S; Kee HJ; Ryu Y; Choi SY; Kim GR; Kim HS; Kee SJ; Jeong MH
Sci Rep; 2019 Feb; 9(1):3018. PubMed ID: 30816171
[TBL] [Abstract][Full Text] [Related]
3. Dendropanax morbifera Prevents Cardiomyocyte Hypertrophy by Inhibiting the Sp1/GATA4 Pathway.
Sun S; Li T; Jin L; Piao ZH; Liu B; Ryu Y; Choi SY; Kim GR; Jeong JE; Wi AJ; Lee SJ; Kee HJ; Jeong MH
Am J Chin Med; 2018; 46(5):1021-1044. PubMed ID: 29986596
[TBL] [Abstract][Full Text] [Related]
4. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
[TBL] [Abstract][Full Text] [Related]
5. 4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress.
Luo T; Chen B; Wang X
Chem Biol Interact; 2015 Dec; 242():99-106. PubMed ID: 26428355
[TBL] [Abstract][Full Text] [Related]
6. GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model.
Hu X; Li T; Zhang C; Liu Y; Xu M; Wang W; Jia Z; Ma K; Zhang Y; Zhou C
J Cell Mol Med; 2011 Sep; 15(9):1865-77. PubMed ID: 20874724
[TBL] [Abstract][Full Text] [Related]
7. Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction.
Cheng M; Wu G; Song Y; Wang L; Tu L; Zhang L; Zhang C
Cell Physiol Biochem; 2016; 38(5):1928-38. PubMed ID: 27160852
[TBL] [Abstract][Full Text] [Related]
8. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
9.
Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH
Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488
[TBL] [Abstract][Full Text] [Related]
10. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure.
Bisping E; Ikeda S; Kong SW; Tarnavski O; Bodyak N; McMullen JR; Rajagopal S; Son JK; Ma Q; Springer Z; Kang PM; Izumo S; Pu WT
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14471-6. PubMed ID: 16983087
[TBL] [Abstract][Full Text] [Related]
11. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.
Yamamura S; Izumiya Y; Araki S; Nakamura T; Kimura Y; Hanatani S; Yamada T; Ishida T; Yamamoto M; Onoue Y; Arima Y; Yamamoto E; Sunagawa Y; Yoshizawa T; Nakagata N; Bober E; Braun T; Sakamoto K; Kaikita K; Morimoto T; Yamagata K; Tsujita K
Hypertension; 2020 Jan; 75(1):98-108. PubMed ID: 31735083
[TBL] [Abstract][Full Text] [Related]
13. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor, mocetinostat, regulates cardiac remodelling and renin-angiotensin system activity in rats with transverse aortic constriction-induced pressure overload cardiac hypertrophy.
Kim GJ; Jung H; Lee E; Chung SW
Rev Cardiovasc Med; 2021 Sep; 22(3):1037-1045. PubMed ID: 34565105
[TBL] [Abstract][Full Text] [Related]
15. Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure.
Jin L; Sun S; Ryu Y; Piao ZH; Liu B; Choi SY; Kim GR; Kim HS; Kee HJ; Jeong MH
Sci Rep; 2018 Jun; 8(1):9302. PubMed ID: 29915390
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.
Weng LQ; Zhang WB; Ye Y; Yin PP; Yuan J; Wang XX; Kang L; Jiang SS; You JY; Wu J; Gong H; Ge JB; Zou YZ
Acta Pharmacol Sin; 2014 Aug; 35(8):1005-14. PubMed ID: 24998254
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
Beckles DL; Mascareno E; Siddiqui MA
Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
19. Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy.
Li X; Le HT; Sato F; Kang TH; Makishima M; Zhong L; Liu Y; Guo L; Bhawal UK
Biochem Biophys Res Commun; 2020 Nov; 532(4):513-519. PubMed ID: 32896382
[TBL] [Abstract][Full Text] [Related]
20. Protocatechuic acid attenuates isoproterenol-induced cardiac hypertrophy via downregulation of ROCK1-Sp1-PKCγ axis.
Bai L; Kee HJ; Han X; Zhao T; Kee SJ; Jeong MH
Sci Rep; 2021 Aug; 11(1):17343. PubMed ID: 34462460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
